Lupin informs about press release

16 Jul 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2165.00 -13.20 (-0.61%)
20-Jan-2026 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.90
Dr. Reddys Lab 1170.15
Cipla 1390.00
Zydus Lifesciences 879.85
Lupin 2165.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×